One Capital Management »

Catalyst Pharmaceutical Partners shares owned by One Capital Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by One Capital Management from 13F filings

Historical chart of One Capital Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by One Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by One Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $917k 47k 19.70
2025-06-30 $581k 27k 21.70

More positions owned by One Capital Management

iShares 5-10 Year Investment Grade Corp Bond ETF Ishs 5-10yr Invt (IGIB)
iShares National Muni Bond ETF National Mun Etf (MUB)
FundX Future Fund Opportunities Fundx Invt Tr (FFOX)
NVIDIA Corporation (NVDA)
Dimensional Intern Core EQT MKT ETF Intl Core Eqt Mk (DFAI)
ONE Global ETF The Future Fund (FFND)
iShares Broad USD High Yield Corp Bond ETF Broad Usd High (USHY)
iShares 1-5 Year Investment Grade Corporate Bond ETF Ishs 1-5yr Invs (IGSB)
Microsoft Corporation (MSFT)
WisdomTree U.S. Quality Dividend Growth ETF Us Qtly Div Grt (DGRW)
First Trust Senior Loan ETF Senior Ln Fd (FTSL)
FundX ETF Fundx Etf (XCOR)
JPMorgan US Quality Factor ETF Us Qualty Fctr (JQUA)
FundX Flexible ETF Flexible Etf (XFLX)
Invesco QQQ Trust Unit Ser 1 (QQQ)

View all positions for One Capital Management

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Renaissance Technologies
Fundsmith
Morgan Stanley
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
Royce & Associates
Millennium Management
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners